Document Detail

Ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances HBV-specific humoral and CTL immune responses in vivo.
MedLine Citation:
PMID:  25135878     Owner:  NLM     Status:  Publisher    
Therapeutic strategies based on an enhanced hepatitis B virus (HBV)-specific cytotoxic T lymphocyte (CTL) activity may eradicate HBV. We previously verified that a fusion protein ubiquitin (Ub)-hepatitis B core antigen (HBcAg)-cytoplasmic transduction peptide (CTP) can enter the cytoplasm of dendritic cells and enhance T cell response to generate HBV-specific CTLs efficiently in vitro. Ub, a marker of protein degradation, may promote the generation of peptides appropriate for major histocompatibility complex class I presentation. In the present study, the specific immune responses of the fusion protein Ub-HBcAg-CTP in BALB/c mice were evaluated and the underlying mechanisms were investigated. Results showed that Ub-HBcAg-CTP increased the anti-HBcAg titer and produced the cytokines IFN-γ and IL-2. This fusion protein also induced higher percentages of IFN-γ(+)CD8(+) cells and specific CTL responses. Ub-HBcAg-CTP could also upregulate the expressions of Jak2, Tyk2, STAT1, and STAT4 in T lymphocytes. In conclusion, Ub-HBcAg-CTP enhanced cellular and humoral immune responses and induced robust HBV-specific CTL activities in BALB/c mice.
Linlin Song; Meng Zhuo; Yuyan Tang; Xiaohua Chen; Zhenghao Tang; Guoqing Zang
Related Documents :
8623908 - Chemokines and t lymphocyte recruitment to lymph nodes in hiv infection.
11861498 - Expression, hormonal regulation, and cyclic variation of chemokines in the rat ovary: k...
12860148 - Infection of human monocytes with mycobacterium bovis bcg induces production of cc-chem...
11432208 - Chemokines in immunity.
22563398 - Amniotic epithelial cells from the human placenta potently suppress a mouse model of mu...
23965458 - Immunolocalization of bcl-2 oncoprotein in amlodipine-induced gingival overgrowth.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-8-15
Journal Detail:
Title:  International immunopharmacology     Volume:  -     ISSN:  1878-1705     ISO Abbreviation:  Int. Immunopharmacol.     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-8-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100965259     Medline TA:  Int Immunopharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014. Published by Elsevier B.V.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Computed tomography-guided reoperation for neurogenic thoracic outlet syndrome.
Next Document:  NG as a novel nitric oxide donor induces apoptosis by increasing reactive oxygen species and inhibit...